Creative Planning
IMNM icon

Creative Planning’s Immunome IMNM Stock Holding History

Creative Planning’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$509K Sell
24,008
-1,510
-6% -$32.3K ﹤0.01% 3171
2026
Q1 		$558K Buy
25,518
+4,637
+22% +$103K ﹤0.01% 2948
2025
Q4 		$449K Buy
20,881
+2,217
+12% +$38.9K ﹤0.01% 2934
2025
Q3 		$219K Buy
18,664
+710
+4% +$7.06K ﹤0.01% 3394
2025
Q2 		$167K Buy
+17,954
New +$147K ﹤0.01% 3293
2025
Q1 		– Sell
-233
Closed -$2.47K – 3593
2024
Q4 		$2.47K Buy
+233
New +$2.82K ﹤0.01% 3449

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Creative Planning's IMNM Position: Q2 2026 in Review

Creative Planning reduced its Immunome (IMNM) stake by 5.9% in Q2 2026, selling an estimated $32.3K and leaving 24,008 shares worth $509K. The position accounts for ﹤0.01% of the portfolio, ranked #3171.

Creative Planning first reported a position in IMNM in Q4 2024 and has held it in 6 quarters since. The position peaked at $558K in Q1 2026. 203 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Creative Planning held 24,008 shares of Immunome worth $509K as of Q2 2026.
  • Creative Planning sold 1,510 Immunome shares in Q2 2026, an estimated $32.3K.
  • Immunome made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #3171 holding.
  • Creative Planning first reported a position in Immunome in Q4 2024 and has held it in 6 quarters since.
  • Creative Planning's Immunome position peaked at $558K in Q1 2026.
  • 203 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.